Bovine Salivary Gland Extract

Bovine salivary gland extract contains the bioactive peptide SGP-T (submandibular gland peptide-T), which modulates inflammatory responses by inhibiting neutrophil migration and suppressing endotoxin-induced fever. It is used in glandular therapy protocols based on the organotherapy principle that like tissue supports like tissue in the human body.

Origin & History

Bovine salivary gland extract is derived from the salivary glands (particularly parotid and submandibular glands) of cattle, which produce 50-150 liters of saliva daily. The extraction typically involves molecular weight cut-off filtration and fractionation to isolate specific protein components and peptides from the crude salivary gland tissue.

Historical & Cultural Context

No information regarding historical use of bovine salivary gland extract in traditional medicine systems was identified in the research. The extract appears to be primarily a modern research ingredient developed for veterinary and investigational purposes.

Health Benefits

• Anti-inflammatory activity: Animal studies show submandibular gland peptide SGP-T suppressed endotoxin-induced fever and inhibited neutrophil migration (preliminary evidence)
• Immunomodulation: Veterinary studies demonstrated significant antibody production and immune responses in cattle (animal evidence only)
• Anti-allergic effects: SGP-T peptide prevented diarrhea development in ovalbumin-sensitized rats (preliminary evidence)
• Intestinal health support: SGP-T dose-dependently reduced intestinal motility disruption in animal models (preliminary evidence)
• Metabolic biomarker potential: Contains beta-hydroxybutyrate which increases in hyperketonemia (preliminary research)

How It Works

The primary bioactive compound SGP-T (submandibular gland peptide-T) inhibits neutrophil chemotaxis and migration by interfering with prostaglandin and leukotriene signaling cascades involved in acute inflammation. SGP-T has also demonstrated suppression of endotoxin-induced fever responses, likely through modulation of cytokine release including TNF-alpha and IL-1 beta at the hypothalamic level. Additionally, salivary gland extracts contain epidermal growth factor (EGF) and nerve growth factor (NGF), which interact with their respective receptor tyrosine kinases (EGFR and TrkA) to influence tissue repair and neural maintenance.

Scientific Research

The available research focuses primarily on veterinary applications rather than human clinical trials. Key studies include immunization research showing antibody production in cattle and investigations of bioactive peptides like SGP-T demonstrating anti-inflammatory and anti-allergic activities in animal models. No published human clinical trials, randomized controlled trials, or meta-analyses were identified.

Clinical Summary

The majority of available evidence for bovine salivary gland extract comes from in vitro and animal studies rather than controlled human clinical trials, placing it firmly in the category of preliminary evidence. Animal studies in cattle demonstrated measurable antibody production and enhanced immune responses following administration, though direct extrapolation to human physiology remains unvalidated. Studies examining SGP-T specifically showed statistically significant suppression of neutrophil migration and fever in rodent endotoxin models, but no large-scale randomized controlled human trials have been published to date. The overall evidence base is insufficient to establish clinically recommended dosages or confirm therapeutic efficacy in humans.

Nutritional Profile

Bovine salivary gland extract is primarily a protein-rich biological tissue extract. Protein content is the dominant macronutrient, estimated at 60–80% of dry weight, comprising a complex mixture of glycoproteins (notably mucins such as MUC5B and MUC7), proline-rich proteins, statherin, histatins, and cystatins. The bioactive peptide SGP-T (Submandibular Gland Peptide-T) is a key identified compound, a 17-amino acid peptide with reported concentrations in the microgram-per-gram range of glandular tissue. Fat content is low, estimated at 2–5% dry weight, primarily as phospholipids from cellular membranes. Carbohydrate content is present largely as glycan chains attached to mucin glycoproteins (oligosaccharides including sialic acid/N-acetylneuraminic acid, fucose, galactose, N-acetylglucosamine), contributing approximately 10–20% of dry weight. Minerals present include zinc (relevant to immune function, estimated 15–30 µg/g dry weight), calcium, magnesium, sodium, potassium, and trace amounts of iron and copper, consistent with bovine glandular tissue composition. B vitamins (B2, B3, B12) are present at low levels typical of mammalian glandular tissue. Epidermal Growth Factor (EGF) and Nerve Growth Factor (NGF) are documented bioactive compounds in submandibular gland tissue, present at nanogram-per-gram concentrations. Bioavailability of intact peptides such as SGP-T via oral route is considered limited due to gastrointestinal proteolysis, though some resistance to digestion has been noted for certain glycoproteins; enteric formulations may improve delivery. Data on precise micronutrient concentrations in commercial extracts is limited due to variable extraction and processing methods.

Preparation & Dosage

No clinically studied dosage ranges for bovine salivary gland extract in human supplementation were identified in the available literature. Animal studies used intravenous injection of peptides at 100 μg/kg, but oral dosing protocols for humans are not documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other glandular extracts, digestive enzymes, probiotic strains, anti-inflammatory herbs, immune-supporting nutrients

Safety & Interactions

Bovine salivary gland extract carries a theoretical risk of allergic or hypersensitivity reactions, particularly in individuals with known beef or bovine protein allergies. Prion disease transmission is a theoretical concern with any bovine-derived glandular product, though reputable manufacturers source from BSE-free certified herds to mitigate this risk. There are no well-documented drug interactions established in the literature, but caution is warranted when combining with immunosuppressant medications such as corticosteroids or calcineurin inhibitors given its proposed immunomodulatory activity. Safety data in pregnant or breastfeeding women is absent, and use during pregnancy should be avoided until adequate human safety data exists.